Devin M. Veerman
Dr. Molewaterplein 40
Rotterdam, ZH 3015GD, Netherlands
Rotterdam, ZH 3015GD, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 10, 2026
Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 10, 2026
Label-free assessment of a microfluidic vessel-on-chip model with visible-light optical tomography reveals structural changes in vascular networks.
Journal: Lab on a chip
Published: February 05, 2026
Long-term daily light exposure boosts human retinal organoid differentiation.
Journal: Communications biology
Published: January 30, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.
Journal: Cancer communications (London, England)
Published: November 03, 2025
Can evolutionary therapy be applied in non-small cell lung cancer?
Journal: Scientific reports
Published: July 20, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.
Journal: Cancer communications (London, England)
Published: November 20, 2024
Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling.
Journal: Frontiers in bioengineering and biotechnology
Published: October 22, 2024
Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 25, 2024
Clinical implications of nintedanib pharmacokinetics in patients with pulmonary fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 29, 2024
Reply To the Letter to the Editor by Frugé et al.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 19, 2023
Last Updated: 09/26/2026